Literature DB >> 24073613

Risk factors for Clostridium difficile infection in the community: a case-control study in patients in general practice, Denmark, 2009-2011.

L M Søes1, H M Holt2, B Böttiger3, H V Nielsen1, V Andreasen4, M Kemp2, K E P Olsen1, S Ethelberg5, K Mølbak5.   

Abstract

To identify risk factors for Clostridium difficile infection (CDI) in Danish patients consulting general practice with gastrointestinal symptoms, a prospective matched case-control study was performed; cases (N = 259) had positive cultures for toxigenic C. difficile and controls (N = 455) negative cultures. Data were analysed by conditional logistic regression. In patients aged ⩾2 years (138 cases), hospitalization [odds ratio (OR) 8·4, 95% confidence interval (CI) 3·1-23], consumption of beef (OR 5·5, 95% CI 2·0-15), phenoxymethylpenicillin (OR 15, 95% CI 2·7-82), dicloxacillin (OR 27, 95% CI 3·6-211), and extended spectrum penicillins (OR 9·2, 95% CI 1·9-45) were associated with CDI. In patients aged <2 years none of these were associated with CDI, but in a subgroup analysis contact with animals was associated with CDI (OR 8·1, 95% CI 1·0-64). This study emphasizes narrow-spectrum penicillins, and suggests beef consumption, as risk factors for CDI in adults, and indicates a different epidemiology of CDI in infants.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24073613      PMCID: PMC9151208          DOI: 10.1017/S0950268813002380

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  45 in total

1.  Comparison of microscopy and PCR for detection of intestinal parasites in Danish patients supports an incentive for molecular screening platforms.

Authors:  Christen Rune Stensvold; Henrik Vedel Nielsen
Journal:  J Clin Microbiol       Date:  2011-11-16       Impact factor: 5.948

2.  Clostridium difficile: (re)emergence of zoonotic potential.

Authors:  Maja Rupnik
Journal:  Clin Infect Dis       Date:  2010-09-01       Impact factor: 9.079

3.  Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients.

Authors:  L M Søes; I Brock; S Persson; J Simonsen; K E Pribil Olsen; M Kemp
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-10       Impact factor: 3.267

Review 4.  Emergence of Clostridium difficile-associated disease in North America and Europe.

Authors:  E J Kuijper; B Coignard; P Tüll
Journal:  Clin Microbiol Infect       Date:  2006-10       Impact factor: 8.067

Review 5.  Clostridium difficile infection in humans and animals, differences and similarities.

Authors:  E C Keessen; W Gaastra; L J A Lipman
Journal:  Vet Microbiol       Date:  2011-03-26       Impact factor: 3.293

6.  A method for fast and simple detection of major diarrhoeagenic Escherichia coli in the routine diagnostic laboratory.

Authors:  S Persson; K E P Olsen; F Scheutz; K A Krogfelt; P Gerner-Smidt
Journal:  Clin Microbiol Infect       Date:  2007-02-28       Impact factor: 8.067

7.  Recovery of Clostridium difficile from children.

Authors:  E Holst; I Helin; P A Mårdh
Journal:  Scand J Infect Dis       Date:  1981

8.  Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county.

Authors:  T Norén; T Akerlund; E Bäck; L Sjöberg; I Persson; I Alriksson; L G Burman
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

Review 9.  Historical perspectives on studies of Clostridium difficile and C. difficile infection.

Authors:  John G Bartlett
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

10.  A case-control study of community-associated Clostridium difficile infection.

Authors:  M H Wilcox; L Mooney; R Bendall; C D Settle; W N Fawley
Journal:  J Antimicrob Chemother       Date:  2008-04-22       Impact factor: 5.790

View more
  10 in total

1.  History of antimicrobial use and the risk of Dientamoeba fragilis infection.

Authors:  D Röser; J Simonsen; H V Nielsen; C R Stensvold; K Mølbak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-07       Impact factor: 3.267

2.  Indomethacin increases severity of Clostridium difficile infection in mouse model.

Authors:  Juan Muñoz-Miralles; Bruno C Trindade; Pablo Castro-Córdova; Ingrid L Bergin; Leslie A Kirk; Fernando Gil; David M Aronoff; Daniel Paredes-Sabja
Journal:  Future Microbiol       Date:  2018-09-21       Impact factor: 3.165

3.  The incidence and clinical symptomatology of Clostridium difficile infections in a community setting in a cohort of Danish patients attending general practice.

Authors:  L M Søes; H M Holt; B Böttiger; H V Nielsen; M Torpdahl; E M Nielsen; S Ethelberg; K Mølbak; V Andreasen; M Kemp; K E P Olsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-19       Impact factor: 3.267

Review 4.  A possible route for foodborne transmission of Clostridium difficile?

Authors:  Barbara M Lund; Michael W Peck
Journal:  Foodborne Pathog Dis       Date:  2015-01-19       Impact factor: 3.171

5.  Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.

Authors:  David M Faleck; Hojjat Salmasian; E Yoko Furuya; Elaine L Larson; Julian A Abrams; Daniel E Freedberg
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

6.  Efficacy of Antibiotic Suppressive Therapy in Patients with a Prosthetic Joint Infection.

Authors:  Marjan Wouthuyzen-Bakker; Jasperina M Nijman; Greetje A Kampinga; Sander van Assen; Paul C Jutte
Journal:  J Bone Jt Infect       Date:  2017-01-15

7.  Complete Genome Sequences of Historic Clostridioides difficile Food-Dwelling Ribotype 078 Strains in Canada Identical to That of the Historic Human Clinical Strain M120 in the United Kingdom.

Authors:  Anand Kumar; Karen Walston Davenport; Grace Vuyisich; Yuliya A Kunde; Shannon Lyn Johnson; Patrick Sam Guy Chain; Armand Earl Ko Dichosa; Alex Rodriguez-Palacios
Journal:  Microbiol Resour Announc       Date:  2018-09-27

8.  Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection.

Authors:  Malin Inghammar; Henrik Svanström; Marianne Voldstedlund; Mads Melbye; Anders Hviid; Kåre Mølbak; Björn Pasternak
Journal:  Clin Infect Dis       Date:  2021-06-15       Impact factor: 9.079

Review 9.  Association between NSAIDs and Clostridium difficile-Associated Diarrhea: A Systematic Review and Meta-Analysis.

Authors:  Nitipong Permpalung; Sikarin Upala; Anawin Sanguankeo; Suthanya Sornprom
Journal:  Can J Gastroenterol Hepatol       Date:  2016-03-08

Review 10.  Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review.

Authors:  Lauren E Bloomfield; Thomas V Riley
Journal:  Infect Dis Ther       Date:  2016-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.